Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 108 recruiting studies, sorted by proximity — each links to its official registry page
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
Prediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
N/A
Interventional 120 participants sought
Johns Hopkins Community Physicians Frederick — Frederick, Maryland (22.8 mi)
· Sponsor: Johns Hopkins University
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
FMH James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Klein And Associates M D P A — Hagerstown, Maryland (0.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Macular Edema Secondary to Inflammation
Phase 3
Interventional 600 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Kodiak Sciences Inc
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Wound Heal, Ulcer
N/A
Interventional 235 participants sought
US-FAS — Hagerstown, Maryland (0.1 mi)
· Sponsor: ConvaTec Inc.
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Geographic Atrophy of the Macula
Phase 2
Interventional 110 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Galimedix Therapeutics Inc
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: City of Hope Medical Center
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Cancer
N/A
Observational 500 participants sought
Frederick Health Regional System — Frederick, Maryland (22.8 mi)
· Sponsor: Tempus AI
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: Agendia
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
Type2diabetes, Heart Failure
N/A
Interventional 156 participants sought
Johns Hopkins University Comstock Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Johns Hopkins University
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Diabetic Macular Edema (DME)
Phase 3
Interventional 514 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: 4D Molecular Therapeutics
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
National Spine and Pain Centers — Hagerstown, Maryland (0.1 mi)
· Sponsor: Stryker Instruments
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Cumberland Valley Retina Consultants (CVRC) — Hagerstown, Maryland (0.1 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Polymyalgia Rheumatica
Phase 3
Interventional 300 participants sought
Klein and Associates- Site Number : 8400003 — Hagerstown, Maryland (0.1 mi)
· Sponsor: Sanofi
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Wellspan Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Duke University